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E Cape: rock the boat, walk the plank?
A redemptive chapter in the ongoing saga of healthcare in the Eastern 
Cape that now spans nearly 3 years is the tenure and leadership 
of departmental head, Dr Siva Pillay, an astute, wealthy local 
businessman and clinician whose value-driven clean-up cost 1 200 
jobs and began a slow turnaround.
The former national MP who applied his business, IT and medical 
skills to save nearly R1 billion in corruption and wastage, inspiring 
Pretoria to pilot a national multi-agency corruption busting/systems 
overhaul team in his province, is it seems too radical for the Bhisho 
establishment. Elements with serious political pull conspired to slowly 
bleed his vital administrative powers and drain his budget, boosted 
by a clash between Pillay and his political chief, Health MEC Sicelo 
Gqobana. Izindaba’s Chris Bateman, fascinated by Pillay’s unusual 
boldness in a climate where administrative chiefs tend to keep their 
heads down and leave the politicians to make excuses, reports on 
how he came within a hair’s breadth of resigning in early June this 
year, functionally emasculated by politicians who contributed to the 
disenchantment of the Pretoria supplementary clean-up squad.1 Only 
direct intervention by national Health Minister Dr Aaron Motsoaledi 
and ANC Secretary-General Gwede Mantashe saved the day.
Antibiotics
Four papers2-5 take a sober look at antibiotic practices and the 
development of antibiotic-resistant organisms that have serious 
implications for South Africa.
The antibiotic horse has bolted
Decades of poor medical and veterinary antibiotic prescribing and 
lack of regard for the practice of infection prevention and control in 
our hospitals have left South Africa, like the rest of the international 
community, on the brink of a return to an era of untreatable bacterial 
infection. In their editorial2 Mendelson and colleagues paint a sombre 
picture of the emergence of drug-resistant organisms. 
Drug-resistant hospital-acquired infections increase morbidity, 
mortality and the cost of patient management by increasing the 
length of hospital stay, often in expensive intensive care units (ICUs), 
and antibiotic prescribing costs. The situation we find ourselves in 
with multidrug-resistant (MDR) Gram-negative bacteria such as 
carbapenem-resistant Enterobacteriaceae (CRE) cannot be blamed on 
poor patient compliance, or the introduction of resistant strains from 
foreign climes. It is a home-grown problem, generated and perpetuated 
by doctors, nurses and allied healthcare workers in South Africa. For 
resistant Gram-positive bacteria there often remain more expensive 
antibiotic options. However, the situation for managing CRE is much 
more serious. We have become reliant on colistin, a nephrotoxic 
polymixin antibiotic developed in the 1960s. Most worrying of all is 
the total lack of new antibiotics against Gram-negative infections in the 
antibiotic pipeline for the next 10 - 20 years. It is not too late to limit 
the emergence and spread of MDR bacterial infection in South Africa. 
To achieve this there must be a sea change in practice and a means to 
control poor prescribing practices in hospitals.
The spread of carbapenem-resistant Enterobacteriaceae
Brink and colleagues3 examine the emergence and spread of antibiotic-
resistant Gram-negative bacteria that it was predicted would occur. 
This prediction was based on the fact that suboptimal antibiotic 
management (excessive duration, use of multiple often inappropriate 
or unnecessary agents, and virtual absence of de-escalation) was rife 
in clinical practice. CRE have become our ‘worst nightmare’, locally 
and internationally. 
Antibiotic stewardship programmes are crucial to prevent the 
emergence of CRE. Cumulative exposure is likely to be the most 
important factor determining risk of developing a CRE infection. 
The risk also increases with increasing duration of treatment. 
Suboptimal dosing may also be a factor contributing to development 
of resistance. CRE have been identified from device-associated 
infections, particularly catheter-associated urinary tract infections. 
Encouragingly, the authors report that the ‘The Best Care … Always’ 
(BCA) campaign, initiated in 2009  to support southern African 
healthcare organisations in implementing specific, internationally 
recognised, evidence-based interventions, has shown encouraging 
results.
Prevalence of infection in ICUs
That the emergence of MDR, extensively resistant and pan-resistant 
pathogens and the widespread inappropriate use of antibiotics is 
a global catastrophe receiving increasing attention by health care 
authorities is reiterated by Paruk and colleagues.4 
Antibiotics are commonly prescribed to critically ill patients 
throughout the world, although a large percentage of these are 
inappropriate. Since the antibiotic prescription practices in public 
and private ICUs in South Africa are unknown, the authors studied 
these practices to determine their relationship to patient outcomes. 
They found that antibiotic prescription practices in South African 
ICUs are far from acceptable. They conclude that it is crucial that 
antibiotic stewardship becomes mandatory in South Africa’s ICUs, 
and that this should extend to the prescribing community as a whole. 
Vancomycin and methicillin-resistant Staphylococcus 
aureus
Complementing aspects of the above papers, Cheong and colleagues 
from Malaysia5 evaluated the relationship between the resolution 
of methicillin-resistant Staphylococcus aureus (MRSA) infections 
and trough concentrations of vancomycin. In their critically ill 
population, a vancomycin dose of 15 mg/kg/d was found sufficient to 
produce optimal trough concentrations to eradicate MRSA infections.
Alcohol, advertising and South 
Africa’s youth
Evidence from burden of disease and economic costing studies 
amply indicates that the public health burden from hazardous and 
harmful use of alcohol in South Africa warrants drastic action. The 
government’s threat of banning all alcohol advertising in South Africa 
receives support from four papers with related themes.6-9
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